We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.1B
AUM Growth
+$1.27B
Cap. Flow
+$1.03B
Cap. Flow %
8.56%
Top 10 Hldgs %
10.66%
Holding
624
New
180
Increased
169
Reduced
84
Closed
163

Sector Composition

Rank Sector Weight
1 Technology 15.27%
2 Industrials 13.28%
3 Healthcare 12.87%
4 Consumer Discretionary 10.6%
5 Consumer Staples 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCTL
301
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$6.95M 0.06%
961,979
+904,424
+1,571% +$6.19M
HRTX icon
302
Heron Therapeutics
HRTX
$92.9M
$6.86M 0.06%
523,597
+327,255
+167% +$5.13M
PANW icon
303
Palo Alto Networks
PANW
$297B
$6.74M 0.06%
323,394
-5,025,972
-94% -$120M
FG
304
CALL
DELISTED
FGL Holdings Ordinary Shares
FG
$6.7M 0.06%
675,000
ZTO icon
305
ZTO Express
ZTO
$17.9B
$6.64M 0.05%
+550,000
New +$7.92M
BATS
306
DELISTED
Bats Global Markets, Inc.
BATS
$6.51M 0.05%
194,224
-138,698
-42% -$4.36M
GAP
307
The Gap Inc
GAP
$7.37B
$6.49M 0.05%
+289,106
New +$7.44M
VIRT icon
308
Virtu Financial
VIRT
$4.93B
$6.38M 0.05%
400,000
-475,794
-54% -$6.79M
ARI
309
Apollo Commercial Real Estate
ARI
$885M
$6.31M 0.05%
+379,860
New +$6.38M
HUNTU
310
DELISTED
Hunter Maritime Acquisition Corp. Unit
HUNTU
$6.09M 0.05%
+600,000
New +$6M
FNV icon
311
Franco-Nevada
FNV
$46B
$6.05M 0.05%
+101,200
New +$6.18M
ATRA icon
312
Atara Biotherapeutics
ATRA
$76.1M
$5.8M 0.05%
16,328
+130
+0.8% +$55K
WPM icon
313
Wheaton Precious Metals
WPM
$60.9B
$5.8M 0.05%
+300,000
New +$6.25M
NEWR
314
DELISTED
New Relic, Inc.
NEWR
$5.65M 0.05%
+200,000
New +$6.6M
CSOD
315
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$5.63M 0.05%
133,125
-96,624
-42% -$3.83M
NH
316
DELISTED
NantHealth, Inc
NH
$5.47M 0.05%
36,667
GDS icon
317
GDS Holdings
GDS
$6.41B
$5.32M 0.04%
+618,200
New +$5.88M
OMED
318
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$5.31M 0.04%
689,254
-182,048
-21% -$1.67M
DHR icon
319
Danaher
DHR
$144B
$5.28M 0.04%
76,557
-4,620
-6% -$321K
CAB
320
DELISTED
Cabela's Inc
CAB
$5.08M 0.04%
+86,829
New +$5.39M
MAC icon
321
Macerich
MAC
$6.92B
$5.01M 0.04%
+70,683
New +$5.05M
CLAC
322
CALL
DELISTED
Capitol Acquisition Corp. III
CLAC
$4.97M 0.04%
500,000
APOL
323
DELISTED
Apollo Education Group Inc Class A
APOL
$4.95M 0.04%
500,000
-567,241
-53% -$5.17M
SPWH icon
324
Sportsman's Warehouse
SPWH
$46M
$4.93M 0.04%
525,000
+225,000
+75% +$2.13M
SPLK
325
DELISTED
Splunk Inc
SPLK
$4.78M 0.04%
+93,528
New +$5.39M

Similar funds

Alyeska Investment Group's Q4 2016 Portfolio in Review

As of Q4 2016, Alyeska Investment Group held 624 positions worth $12.1B, up 12% from $10.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Alyeska Investment Group deployed $1.03B of net new capital in Q4 2016, opening 180 new positions and adding to 169 existing holdings. Its largest new stake was Texas Instruments: 1,378,860 shares worth $101M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Palo Alto Networks, an estimated $120M trimmed.

  • Alyeska Investment Group's largest Q4 2016 buy was Texas Instruments: 1,378,860 shares worth $101M.
  • Alyeska Investment Group added most to Alphabet (Google) Class A in Q4 2016, an estimated $135M increase.
  • Alyeska Investment Group's biggest Q4 2016 reduction was Palo Alto Networks, cutting an estimated $120M.
  • Alyeska Investment Group fully exited Apple in Q4 2016, selling an estimated $217M.
  • Alyeska Investment Group's ten largest holdings make up 11% of its $12.1B portfolio in Q4 2016.
  • Alyeska Investment Group opened 180 new positions and closed 163 in Q4 2016.
  • Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $12.1B.

Based on Alyeska Investment Group's 13F filing for Q4 2016, filed 14 Feb 2017.